The gender specific frequency of risk factor and CHD diagnoses prior to incident MI: A community study by Yawn, Barbara P et al.
BioMed  Central
Page 1 of 9
(page number not for citation purposes)
BMC Family Practice
Open Access Research article
The gender specific frequency of risk factor and CHD diagnoses 
prior to incident MI: A community study
Barbara P Yawn*1, Peter C Wollan1, Roy A Yawn2, Steven J Jacobsen3 and 
Veronique Roger4
Address: 1Department of Research, Olmsted Medical Center, Rochester, MN, USA, 2Department of Internal Medicine, Olmsted Medical Center, 
Rochester, MN, USA, 3Southern California Permanente Medical Group, Pasadena, CA, USA and 4Division of Cardiovascular Diseases, Mayo Clinic, 
Rochester, MN, USA
Email: Barbara P Yawn* - yawnx002@umn.edu; Peter C Wollan - pwollan@olmmed.org; Roy A Yawn - ryawn@olmmed.org; 
Steven J Jacobsen - Steven.J.Jacobsen@kp.org; Veronique Roger - roger.veronique@mayo.edu
* Corresponding author    
Abstract
Background:  CHD is a chronic disease often present years prior to incident AMI. Earlier
recognition of CHD may be associated with higher levels of recognition and treatment of CHD risk
factors that may delay incident AMI. To assess timing of CHD and CHD risk factor diagnoses prior
to incident AMI.
Methods: This is a 10-year population based medical record review study that included all
medical care providers in Olmsted County, Minnesota for all women and a sample of men residing
in Olmsted County, MN with confirmed incident AMI between 1995 and 2000.
Results: All medical care for the 10 years prior to incident AMI was reviewed for 150 women and
148 men (38% sample) in Olmsted County, MN. On average, women were older than men at the
time of incident AMI (74.7 versus 65.9 years, p < 0.0001). 30.4% of the men and 52.0% of the
women received diagnoses of CHD prior to incident AMI (p = 0.0002). Unrecognized and
untreated CHD risk factors were present in both men (45% of men 5 years prior to AMI) and
women (22% of women 5 years prior to first AMI), more common in men and those without a
diagnosis of CHD prior to incident AMI (p < 0.0001).
Conclusion: A CHD diagnosis prior to incident AMI is associated with higher rates of recognition
and treatment of CHD risk factors suggesting that diagnosing CHD prior to AMI enhances
opportunities to lower the risk of future CHD events.
Background
Coronary heart disease (CHD) is the leading killer of men
and women in the United States. [1-5] Until recently CHD
was considered primarily a man's disease among the lay
population [6-10] and among many health professionals
as well. [11-22] Despite the many studies of CHD in men
and women few have addressed the potentially most
important period primary care physicians have in prevent-
ing coronary events and deaths, the time before the first
coronary event. The pre-incident AMI period may provide
a significant opportunity for primary care physicians to
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recognize and treat CHD risk factors, potentially prevent-
ing or delaying cardiac events and death.[16-18,23-28]
This study uses data from the 10-years prior to incident
AMI in men and women to evaluate and compare the tim-
ing of first CHD diagnosis and its relation to recognition
and treatment of potentially modifiable CHD risk fac-
tors.[26,29-50] This information should be helpful in
determining any gaps that exist in the current adoption of
CHD prevention guidelines in practice and suggest areas
where a differing emphasis may be required for translat-
ing those guidelines into care of men and
women.[7,18,20,21,51-53]
Methods
Overview of Design
This is a population-based observational study based on
review of the medical records. The subjects are the patients
of the physician members of the Rochester Epidemiology
Project that includes all physicians providing healthcare
in Olmsted County, Minnesota. This retrospective study
examines CHD diagnoses and recognition and treatment
of CHD risk factors in the 10 years before incident AMI or
date of non-hospital death from incident AMI. Beginning
with a confirmed diagnosis of AMI assures that all people
included in the study indeed have CHD. Including other
possible indicators of CHD such as a diagnosis of angina
or people with angiographic diagnosis of CHD would
introduce selection bias.[4-6,52,54-57] Previous work has
demonstrated that not all "angina" is actually related to
CHD and that men and insured patients are more likely to
be referred for angiography, thereby selectively excluding
many women and uninsured people.
Study setting
Olmsted County, MN is a metropolitan statistical area sur-
rounded by farming communities. Rochester, the county
seat, is 90 miles south of the twin cities of Minneapolis
and St Paul, Minnesota. The county's population is rela-
tively isolated from other urban centers and its residents
obtain over 98% of their primary and tertiary medical care
within the metropolitan area of Rochester, Minne-
sota.[58]
The Rochester Epidemiology Project (REP) provides link-
ing of data on all health care services delivered to the pop-
ulation of Rochester, MN and Olmsted County, MN by
any Olmsted County provider. Ambulatory, emergency
department (ED), urgent care and hospital diagnostic and
procedure data are linked to all medical records from all
primary and specialty care providers in the county. Each
person residing within the county who has ever visited
any health care provider within the county has a unique
REP ID number that links the diagnostic and procedure
indexes to all of their personal medical records across all
care sites.[58,59]
Patients
The Olmsted County population is largely white (92%)
and middle class with over 82% of adult residents having
at least a high school education. The population charac-
teristics are similar to that of the US white population
with the exception of more citizens working in the health
care industry, slightly more (about 7% more) adults hav-
ing completed 4 or more years of college and a lower than
average rate of no health insurance (4.5%)[60]. Excluding
people who were not residents of Olmsted County for at
least 3 years prior to their first MI (n = 18 of potentially eli-
gible subjects) assured the availability of sufficient longi-
tudinal data to assess timing of CHD diagnosis before
AMI and decreased the potential selection bias associated
with men or women who moved to Olmsted County spe-
cifically to receive care for their CHD at the Mayo Clinic.
Data collection
After approval by the Olmsted Medical Center and the
Mayo Foundation Institutional Review Boards, each Olm-
sted County man or woman identified with a diagnostic
code for an AMI between January 1, 1996 and December
31, 2001 had that diagnosis verified based on Gillum's
previously published and validated AMI criteria used in
several large national AMI research studies.[17,61,62] We
chose to use these very specific research criteria to assure
that patients had experienced an AMI.[5,62] Each poten-
tially eligible patient's medical record was reviewed by a
trained cardiac research nurse abstracter to assure that it
met the criteria for AMI and then rechecked by one of the
authors (VR).[63] From this group with confirmed AMIs,
verification that the AMI was the incident AMI was done
by trained research nurse abstracters reviewing all availa-
ble medical records and excluding any person with a his-
tory of previous AMI. Troponin was not included in the
definition of AMI since it was not available or used rou-
tinely in this setting until 2000 and its use might therefore
introduce temporal bias.[5]
All women with confirmed incident AMIs who met the
inclusion criteria were included. Sample size calculations
based on the assumption that about 30% of men and
women would have a pre-AMI diagnosis of CHD sug-
gested that an equivalent sample of 165 men and 165
women would be sufficient to identify a 10% or greater
gender difference in the rate of pre-AMI diagnoses of
CHD. Only 150 women were available in the time period
so that an equivalent size sample of men was selected. The
150 men represent 38.1% of all 394 eligible male candi-
dates. The men included were selected by random sam-
pling by year from men with verified incident AMIs until
the number of men selected was equal to the number ofBMC Family Practice 2007, 8:18 http://www.biomedcentral.com/1471-2296/8/18
Page 3 of 9
(page number not for citation purposes)
women included from that year. Two of the 150 men had
to be dropped from the analysis after their families
refused continuing research authorization as required by
Minnesota statute.
Initial diagnosis of CHD
To obtain data on the initial physician diagnosis of CHD
and assessment and treatment of potentially remediable
risk factors, the trained research nurses reviewed the entire
medical record(s) of each subject including correspond-
ence, laboratory test results and imaging results as well as
clinic, urgent care, emergency department and hospital
notes. Identification of the first CHD diagnosis was based
on documented diagnoses found in the physician notes
including the review of systems, past medical history and
final diagnoses. Diagnoses prefaced by words such as
"probable" or "likely" were included while diagnoses pre-
ceded by "possible", "rule out" or "consider" were
excluded. These decisions were based on the expert opin-
ions of the physician authors and their familiarity with the
use of qualifying terms used in the Olmsted County med-
ical records. In those cases without a prior physician
recorded CHD diagnosis, the incident AMI was consid-
ered the first CHD diagnosis. Due to the high reliance on
nurse abstractors for data collection, extensive testing of
inter- and intra-rater reliability for data abstraction was
undertaken and has been published previously.[64]
Identification and treatment of risk factors
All records were searched for statements regarding the
presence, absence or evaluation of the traditional and
modifiable CHD risk factors including diabetes mellitus,
hypertension, elevated serum lipids (cholesterol, choles-
terol subtypes and triglycerides), obesity, and cigarette
smoking.[26,29-50] For those risk factors that were
already being treated at the beginning of the data collec-
tion period, the date of risk factor evaluation and date of
treatment were recorded as "greater than 10 years, date
unknown". Each risk factor required specific notation in
the chart to be included as assessed or present. For exam-
ple, 3 instances of blood pressures > 140/90 in the vital
signs records was considered to be consistent with the per-
son having hypertension but was not considered as diag-
nosed or treated hypertension unless a physician note
stated hypertension or an anti-hypertensive medication
was recorded as prescribed. Despite the recording of
weight at nearly every visit, only documentation of "obes-
ity" or a synonym such as "over-weight" or "high BMI" in
a clinician's note or a recommendation for dietary modi-
fication, weight loss, referral to a dietician, weight reduc-
tion program or prescribing a weight reduction
medication was considered recognition of obesity.
Data analysis
Descriptive statistics were used to detail the demographics
of the women and men. Presence of a diagnosis of CHD
prior to incident AMI, presence of risk factors, and treat-
ment of risk factors, are reported as simple proportions
and compared between men and women using Chi-
squared tests. Association between presence of a CHD
diagnosis and age and gender was modeled using logistic
regression. Wilcoxon rank-sum tests were used to com-
pare means between men and women.
Since both CHD and its risk factors are chronic condi-
tions, recognition at any time is likely to have been noted
in later physician visits, so the fact that subjects had differ-
ing follow up times does not affect these proportions of
those identified prior to AMI. However, we also report
data on timing of CHD diagnosis and identification of
risk factors, as mean time before incident AMI and as
cumulative proportions (Figures 1 and 2). Subjects who
had less than 10 years of residency prior to AMI, and
whose first documented diagnosis occurred at the first
recorded visit, could have had an earlier diagnosis that
was made at a site outside Olmsted County and therefore
not found in this study. To address this, we carried out a
sensitivity analysis, calculating mean time from diagnosis
to AMI in two ways, using the observed date for these sub-
jects and also using the maximum possible interval of 10
years. Since the effect of this recalculation was minimal,
Figures 1 and 2 are presented using only the observed
interval.
Results
All 150 women and 148 men were white non-Hispanic.
The women were on average older than the men at the
Timing of identification of abnormal risk factors in men Figure 1
Timing of identification of abnormal risk factors in 
men. The vertical lines at time 0 represents risk factors first 
evaluated at time of incident MI.
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time of incident AMI [74.7 years (st.d. 12.6, range 38.9 to
99.8) versus 65.9 years (st.d. 13.6 range 39.1 to 94.4) (p <
0.0001)]. Most subjects had completed high school
(80.0% for women and 79.1% for men) and about one
third attended or graduated from college (33.3% of the
women and 35.1% of the men). The average duration of
available observations for the ten years prior to the inci-
dent AMI was similar for the men and women (9.2 years,
st.d. 1.4, range 3 to 10 years for the women and 8.2 years,
st.d. 2.1 range 3.3 to 10 years for the men). Twenty-four
subjects (18 men and 6 women) had less than 5 years of
observation.
Women were significantly more likely than the men to
have CHD diagnosed prior to their incident AMI (52.0%
versus 30.4% respectively, p = 0.0002). For those subjects
who received a CHD diagnosis prior to their incident AMI,
the mean time between diagnosis and AMI was 5.1 years
and was not different for men and women (p=.86). Fif-
teen subjects (6 men and 9 women) had their first
recorded CHD diagnosis at the first observed physician
visit; replacing the observed interval for these subjects
with the maximum interval of 10 years raised the means
to 5.3 years for both men and women (p = .94). Both age
and sex were independently associated with receiving a
CHD diagnosis prior to incident AMI (p < .0001, p = .02
respectively). Women > 70 years of age and men > 60 were
demonstrably more likely to have a CHD diagnosis prior
to incident AMI than younger women and men. Table 1
groups men and women into ten year age intervals to fur-
ther demonstrate the effect of both age and gender on the
diagnosis of CHD prior to incident AMI.
Assessment of traditional CHD risk factors was common
prior to incident AMI (Table 2). Five years prior to their
incident AMI, 78.7% of women had been assessed for the
presence of smoking, obesity, hypertension, hyperlipi-
demia and elevated glucose levels. Only 55.4% of men
had been similarly assessed by 5 years prior to their inci-
dent AMI. The difference in assessment rates was due
almost entirely to the less frequent evaluation of serum
glucose in men compared to women (p = 0.0003). To
account for differential follow up, a sensitivity analysis
was done assuming that the two subjects who had follow-
up of less than 5 years and had a diagnosis of CHD docu-
mented at their first physician visit, had a diagnosis at 10
years prior to AMI. This changed the above percentages or
risk factor assessment from 78.4% to 79.3% in women
and from 55.4% to 56.1% in men.
Women were more likely than men to have hypertension
(p = 0.0001) and elevated lipids (p = 0.002) whereas men
were more likely than women to be and to remain active
smokers during the ten-year period prior to their incident
AMI (p = 0.003) (Figures 1 and 2).
Not all test abnormalities resulted in diagnoses and not all
diagnosed CHD risk factors were treated in either men or
women (Table 2). For example, all men and women had
multiple blood pressure measurements recorded in their
medical records. Prior to incident AMI, 77% of the
women (n = 115) and 45% of the men (n = 67) had a
diagnosis of hypertension in their medical records (p =
0.0001). Of those subjects with documented diagnoses of
hypertension, 91.3% of the women and 91.0% of the men
were noted to be receiving anti-hypertensive therapy.
However, if all men and women with 3 or more blood
Table 1: Number of subjects with a diagnosis of CHD prior to incident AMI by decade of age for men and women
< 50 50–59 60–69 70–79 80+
Women N = 150 N = 4 N = 24 N = 25 N = 43 N = 54
CHD Diagnosis prior to MI 0 (0%) 6 (33%) 12 (48%) 24 (56%) 36 (67%)
No CHD Diagnosis prior to MI 4 (100%) 18 (67%) 13 (52%) 19 (44%) 18 (33%)
Men N = 148 N = 20 N = 34 N = 32 N = 34 N = 28
CHD Diagnosis prior to MI 2 (10%) 9 (26%) 7 (22%) 13 (38%) 14 (50%)
No CHD Diagnosis prior to MI 18 (90%) 25 (74%) 25 (78%) 21 (62%) 14 (50%)
Timing of identification of abnormal risk factors in women Figure 2
Timing of identification of abnormal risk factors in 
women. The vertical lines at time 0 represents risk factors 
first evaluated at time of incident MI.
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pressures > 140/90 in a period of six months or less were
considered to be hypertensive, only 80.8% of women vs.
69.3% of men, p = 0.08 were treated. The percent of
women and men treated for hypertension was greater
among those with a pre-AMI diagnosis of CHD (p = .0001
and .0002 for men and women respectively) suggesting
that a CHD diagnosis is important in the decision to treat
hypertension.
Treatment for elevated lipids is worth special note due to
the low rates of medication therapy even as recently as
1995 through 2000. In women only 76% of the 116
women with elevated lipids had a physician diagnosis of
hyperlipidemia and of the 88 diagnosed, 73 received
some form of therapy. Only 33 women (37.5% of diag-
nosed and 28.4% of those with abnormal lipids) received
drug therapy. The data is not better for men with 73% of
the 88 men with abnormal lipid levels having a physician
diagnosis of hyperlipidemia and only 64 receiving some
type of therapy. Only 22 men (29% of diagnosed and
18% of those with abnormal lipids) were treated with
drugs. The presence of a diagnosis of CHD increased the
likelihood of drug therapy (p = 0.0001) supporting the
apparent importance of an antecedent CHD diagnosis.
Smoking was the only CHD risk factor more likely to be
present in men than in women prior to their incident
AMI, with 106 (71.6%) men reported as smoking at some
time compared to 70 (47.0%) women (P = 0.001) (Table
2). At 5 years prior to their first AMI, 47 men (31.8%) and
36 women (24.0%) continued to smoke. Current and ever
smoking were associated with a lower rate of pre-AMI
diagnosis of CHD in both men (p = 0.01) and women (p
= 0.001).
By the time of incident AMI, 98% of women and 90% of
men had at least one CHD risk factor present, if not diag-
nosed. Five years before incident AMI, 89.5% of women
and 85% of men had one or more risk factors present
(Table 3). Having more risk factors diagnosed was associ-
Table 2: Risk factor recognition and treatment by gender and presence of CHD diagnosis before AMI
CHD Diagnosis Prior to AMI No CHD Diagnosis Prior to AMI
Male N = 148 Female N = 150 Male N = 45 Female N = 78 Male N = 103 Female N = 72
Lipids
Evaluated before MI 122 (82%) 138 (92%) 41 (91%) 76 (97%) 81 (79%) 62 (86%)
Abnormal before MI 103 (70%) 116 (77%) 40 (89%) 69 (88%) 63 (61%) 47 (65%)
Diagnosed before MI 75 (51%) 88 (59%) 33 (73%) 54 (69%) 42 (41%) 34 (47%)
Treated: Percent is of those with diagnosed hyperlipidemia
Diet/exercise only 42 (56%) 41 (47%) 14 (42%) 21 (39%) 29 (69%) 19 (56%)
Statins 18 (24%) 13 (15%) 11 (33%) 12 (22%) 8 (19%) 2 (6%)
Resins, fibrates, niacin 4 (5%) 19 (22%) 3 (9%) 13 (24%) 1 (2%) 6 (18%)
Blood pressure
Evaluated before MI 148 (100%) 150 (100%) 45 (100%) 78 (100%) 103 (100%) 72 (100%)
Abnormal before MI 88 (59%) 130 (87%) 41 (91%) 74 (95%) 47 (46%) 56 (78%)
Diagnosed before MI 67 (45%) 115 (77%) 39 (87%) 73 (94%) 28 (28%) 42 (58%)
Treated: Percent is of those with diagnosed hypertension 61 (91%) 105 (91%) 37 (95%) 69 (95%) 24 (86%) 36 (86%)
Smoking
Evaluated before MI 139 (94%) 149 (99%) 43 (96%) 77 (99%) 96 (93%) 72 (100%)
Smoked ever 106 (72%) 70 (47%) 33 (73%) 30 (38%) 73 (71%) 40 (56%)
Active smoker (5 yrs before AMI) 47 (32%) 36 (24%) 7 (16%) 9 (12%) 40 (39%) 27 (38%)
Treated: Percent is of those with active smoking 5 years 
prior to AMI
Counseling only 8 (17%) 13 (36%) 1 (14%) 4 (44%) 7 (18%) 9 (33%)
NRT 17 (36%) 12 (33%) 5 (71%) 3 (33%) 12 (30%) 9 (33%)
Other 5 (11%) 4 (11%) 0 (0%) 1 (11%) 5 (13%) 3 (11%)
None 17 (11%) 7 (5%) 1 (2%) 1 (1%) 16 (16%) 6 (8%)
Glucose
Evaluated before MI 127 (86%) 147 (98%) 45 (100%) 78 (100%) 82 (80%) 69 (96%)
Abnormal before MI 57 (39%) 91 (61%) 35 (78%) 55 (71%) 22 (21%) 36 (50%)
DM diagnosed 25 (17%) 44 (29%) 14 (31%) 26 (33%) 11 (11%) 18 (25%)
Treated: Percent is of those with diagnosed diabetes
Diet/exercise only 5(20%) 10 (23%) 4 (29%) 7 (27%) 1 (9%) 3 (17%)
Oral hypoglycemics 12 (48%) 11 (25%) 5 (36%) 6 (23%) 7 (64%) 5 (28%)
Insulin 3 (12%) 12 (27%) 1 (7%) 5 (19%) 2 (18%) 7 (39%)
None 6 11 4 8 2 3
(24%) (25%) (29%) (31%) (18%) (17%)
Family History
Evaluated before MI 145 (98%) 148 (99%) 45 (100%) 77 (99%) 100 (97%) 71 (99%)
Positive history 99 (67%) 118 (79%) 30 (67%) 67 (86%) 69 (67%) 51 (71%)BMC Family Practice 2007, 8:18 http://www.biomedcentral.com/1471-2296/8/18
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ated with a greater likelihood of having a CHD diagnosis
before AMI in men (p = 0.001) but not in women (p =
0.16).
Discussion and Conclusion
This study provides an overview of the diagnosis of CHD
and the diagnosis and treatment of CHD risk factors in a
10-year period before incident AMI. While it has been
known that men are more likely than women to have their
first diagnosis of CHD at the time of incident AMI, no pre-
vious studies have provided the longitudinal gender-spe-
cific data to describe the differences in timing of CHD
diagnosis or in risk factor evaluation or treatment prior to
incident AMI. The higher rates of CHD diagnosis in
women versus men were present at all ages. There were
also within gender differences with older people more
likely to have CHD recognized and diagnosed prior to
incident AMI. While women have more traditional risk
factors identified than men prior to incident MI, few men
or women had no CHD risk factors identified prior to
their incident AMI. A diagnosis of CHD prior to AMI
increased the likelihood of recognition and treatment of
CHD risk factors.
The medical literature suggests that a gender bias exists,
with women receiving less attention than men for their
heart disease.[2,12,20-22,25] Our data suggest the picture
is more complex. Indeed, men have been shown to have
more intense CHD diagnostic evaluations after AMI or
after an unstable angina episode or after the diagnosis of
CHD compared to women. Other work reports that
women are more likely to have recognized angina for a
longer period prior to their first cardiac event and since
angina is consider synonymous with a diagnosis of CHD
women are more likely to have a CHD diagnosis before
incident AMI.[6] Therefore, women may be more likely to
present with angina symptoms but less likely to present
with the events that have been traditionally been studied
such as unstable angina or referral for an angiography.
Once a CHD diagnosis is established based on the occur-
rence of a cardiac event such as AMI or unstable angina,
there may be a greater likelihood that men receive addi-
tional testing or aggressive intervention.[7,18,32] This
still leaves potential opportunities for earlier diagnosis of
CHD in men that have not had an event such as unstable
angina. Our data suggest that the early recognition of
CHD may also lead to greater attention to risk factor iden-
tification and treatment.
Almost half of the women and 70% of the men did not
have CHD recognized prior to incident AMI. Yet, CHD
risk factors were common in both men and women prior
to their first MI.[26,47,48] In this cohort; risk factors are
more common among women. Some of the difference is
likely to be due to the older average age of the women at
first AMI. However, in comparable age groups, women
still have more risk factors on average than the men. Many
of the men and women both with and without diagnosed
CHD had one or more CHD risk factors recognized prior
to their incident AMIs that were either not treated or
incompletely treated. In particular there was a lack of drug
treatment for elevated lipids and smoking cessation sup-
port. Similar data have been presented previously but
only regarding the presence or absence of risk factors at
the time of the AMI and have not been described in the
pre-AMI period. [65-71]
The reasons for the difference in rates of diagnoses of
CHD prior to the patient's incident AMI cannot be pro-
vided with the data described. It is possible that men have
fewer visits for CHD like symptoms due either to the lack
of such symptoms or the failure to recognize or desire to
have such symptoms evaluated. It is also possible that
women have more symptomatic CHD as has been sug-
gested by the higher rate of angina in women than in men
prior to AMI.
Like all medical record review studies this study is limited
to the data documented in the medical record.[63] How-
ever, the review of 10 years of data allows a much broader
overview than is usually accomplished. While a diagnosis
may not be mentioned in a 6 or even 12-month period, it
is unlikely that a diagnosis is made but not noted in a 10-
year review. Therefore, we believe that most documented
diagnoses of CHD and risk factors were identified and
abstracted. Since information was collected from both the
diagnosis sections as well as clinical sections of all medical
records notes, our data is much richer that that taken only
from administrative data that are a filtered set of only the
diagnoses the physician or billing group choose to record.
Although this is a population-based study it is possible
that some people with CHD and AMI did not seek medi-
Table 3: Modifiable risk factors identified 5 years prior to incident AMI by gender
Number and (%) of people with recognized risk factors
Number of risk factors recognized 0 1 2 3 4 or more
Women N = 150 16 (11%) 43 (29%) 42 (28%) 31 (21%) 18 (12%)
Men N = 148 37 (25%) 59 (40%) 30 (20%) 17 (11%) 5 (3%)BMC Family Practice 2007, 8:18 http://www.biomedcentral.com/1471-2296/8/18
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cal care. The observations are limited to recognized AMI
with no attempt to account for "silent" or unrecognized
AMIs. The use of 10 years of longitudinal data from a U.S.
PBRN that includes primary to tertiary outpatient and
inpatient care and records including all laboratory tests
and procedures done in the entire community and across
medical groups is unique. The results allow a clearer
assessment of the duration and depth of the potential
missed opportunities for CHD event prevention.
The racial diversity of the Olmsted County population is
limited especially in the older age groups. This study
should be representative of the U.S. White population but
cannot be extrapolated or generalized to the entire U.S.
population.
In conclusion, these data suggest that there is a gender and
age differential in the recognition of CHD prior to inci-
dent AMI. Men are less likely than women and younger
people (< 70) are less likely than older people to have
their CHD diagnosed prior to first AMI. The diagnosis of
CHD increases the likelihood of recognizing and treating
CHD risk factors suggesting that earlier CHD diagnosis
may provide greater opportunities to address undiag-
nosed and minimally treated potentially modifiable CHD
risk factors before the first cardiac event thereby prevent-
ing or delaying CHD events.
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